Biosynthetic
Irvine, US · 1 known investors
Biosynthetic Technologies manufactures biobased synthetic base oils called Estolides, derived from organic fatty acids in bio-derived oils, that serve as drop-in replacements for conventional lubricant base oils. Its products target industrial lubricants, metalworking fluids, grease, food grade applications, and personal care/beauty ingredients.
Founders & leadership
BM
Bernhard MohrDirector
MS
Meghan SharpDirector
AB
Allen BarbieriExecutive Officer, Director
KW
Kent WassonDirector
SB
Steve BierschenkDirector
JH
John HopkinsDirector
GK
Gerald KohlenbergerDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$16.5MraisedFeb 2017 · 5 investors · ManufacturingRule 506(b)
▶$16.5MraisedFeb 2017 · 5 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Bernhard MohrDirector
- Meghan SharpDirector
- Allen BarbieriExecutive Officer, Director
- Kent WassonDirector
- Steve BierschenkDirector
- John HopkinsDirector
- Gerald KohlenbergerDirector
- Offering amount
- $28M
- Amount sold
- $16.5M
- First sale
- Dec 2016
- Incorporated
- Limited Liability Company, Montana
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.